Page last updated: 2024-12-05

levulinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Levulinic acid is a colorless, water-soluble organic compound with the formula CH3C(=O)CH2CH2COOH. It is a valuable platform chemical derived from biomass, specifically from the acid-catalyzed hydrolysis of carbohydrates like cellulose. Levulinic acid can be produced through various methods, including the dehydration of hexoses, the catalytic conversion of furfural, and the direct hydrolysis of lignocellulosic biomass. Levulinic acid has a wide range of applications, including the synthesis of polymers, pharmaceuticals, and fuels. Its unique chemical structure allows it to participate in various reactions, making it a versatile building block in organic synthesis. Moreover, levulinic acid is a biodegradable and renewable alternative to petrochemical-based products, contributing to a sustainable and environmentally friendly chemical industry. Current research focuses on improving the efficiency and cost-effectiveness of levulinic acid production, exploring new applications for this platform chemical, and understanding its biological activity and potential therapeutic benefits.'

levulinic acid: inhibits 5-aminolevulinic acid dehydratase; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5316 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-oxopentanoic acid : An oxopentanoic acid with the oxo group in the 4-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11579
CHEMBL ID1235931
CHEBI ID45630
SCHEMBL ID20868
MeSH IDM0100761

Synonyms (103)

Synonym
CHEMBL1235931
propionic acid, 3-acetyl-
pentanoic acid, 4-oxo-
.gamma.-ketovaleric acid
leva
4-oxovaleric acid
4-ketovaleric acid
usaf cz-1
acetopropionic acid
.beta.-acetylpropionic acid
nsc3716 ,
valeric acid, 4-oxo-(levulinic acid)
levulinic acid
valeric acid, 4-oxo-
123-76-2
levulic acid
wln: qv2v1
3-acetylpropionic acid
laevulinic acid
nsc-3716
4-oxopentanoic acid
3-acetylpropionsaeure
4-oxopentansaeure
laevulic acid
ai3-03377
acidum laevulinicum
nsc 3716
einecs 204-649-2
pentanoic acid, 4-oxo
fema no. 2627
brn 0506796
pentanoic acid,4-oxo mfc5 h8 o3
inchi=1/c5h8o3/c1-4(6)2-3-5(7)8/h2-3h2,1h3,(h,7,8
levulinic acid, >=97%, fg
levulinic acid, 98%
gamma-ketovaleric acid
laevulinsaeure
CHEBI:45630 ,
3-ketobutane-1-carboxylic acid
beta-acetylpropionic acid
levulinsaeure
DB02239
LMFA01060006
4-oxo-pentanoic acid
4-ketovalerate
laevulinate
gamma-ketovalerate
4-oxovalerate
levulate
3-acetylpropionate
beta-acetylpropionate
STK802043
L0042
AKOS000119608
A805146
NCGC00249052-01
NCGC00256314-01
dtxsid8021648 ,
tox21_302729
cas-123-76-2
dtxcid701648
NCGC00259034-01
tox21_201483
bdbm82191
4-03-00-01560 (beilstein handbook reference)
unii-ryx5qg61ei
ryx5qg61ei ,
FT-0627815
AM20080171
levulinic acid [inci]
levulinic acid [fcc]
levulinic acid [fhfi]
levulinic acid [mi]
S6207
BBL027404
SCHEMBL20868
levulenic acid
acetylpropionic acid
J-004982
J-521643
F2191-0253
mfcd00002796
SR-01000944838-1
sr-01000944838
levulinic acid, analytical standard
D70802
levulinic acid, natural, 99%, fg
b-acetylpropionate
g-ketovaleric acid
g-ketovalerate
b-acetylpropionic acid
CS-0015813
HY-Y0839
1206185-52-5
VS-08535
Q903322
EN300-20219
GEO-04255
levulinicacid
PB48051
4-oxopentanoicacid
levulinic-d5 acid
Z104477318

Research Excerpts

Overview

Levulinic acid (LA) is an important chemical building block listed among the top 12 value-added chemicals by the United States Department of Energy. LA can be obtained through the hydrolysis of lignocellulosic biomass. Levulinic Acid is a versatile platform molecule with potential to be used as an intermediate in the synthesis of many value- added products.

ExcerptReferenceRelevance
"Levulinic acid is a carboxylic acid present in industrial downstream. "( Perspective of reactive separation of levulinic acid in conceptual mixer settler reactor.
Ingle, A; Kumar, A; Shende, DZ; Wasewar, KL, 2023
)
2.62
"Levulinic acid (LA) is a valuable chemical used in fuel additives, fragrances, and polymers. "( A Genetically Encoded Biosensor for the Detection of Levulinic Acid.
Kim, H; Kim, HT; Kim, SJ; Kim, SK; Kim, TH; Kwon, KK; Lee, DH; Lee, H; Lee, SG; Rha, E; Shin, J; Sung, BH; Woo, SG; Yoo, BH, 2023
)
2.6
"Levulinic acid (LA) is an important chemical building block listed among the top 12 value-added chemicals by the United States Department of Energy, and can be obtained through the hydrolysis of lignocellulosic biomass. "( Microbial and enzymatic conversion of levulinic acid, an alternative building block to fermentable sugars from cellulosic biomass.
Habe, H; Kirimura, K; Sato, Y, 2020
)
2.27
"Levulinic acid (LA) is an industrially important product that can be catalytically valorized into important value-added chemicals. "( Catalytic Conversion of Glucose into Levulinic Acid Using 2-Phenyl-2-Imidazoline Based Ionic Liquid Catalyst.
Kumar, K; Kumar, M; Upadhyayula, S, 2021
)
2.34
"Levulinic acid is a versatile platform molecule with potential to be used as an intermediate in the synthesis of many value-added products used across different industries, from cosmetics to fuels. "( Prospecting Biochemical Pathways to Implement Microbe-Based Production of the New-to-Nature Platform Chemical Levulinic Acid.
Ferreira, FC; Islam, MA; Mira, NP; Prather, KLJ; Vila-Santa, A, 2021
)
2.28
"Levulinic acid is an important platform molecule from biomass-based renewable resources. "( Integrated catalytic process to directly convert furfural to levulinate ester with high selectivity.
Chen, B; Huang, Z; Li, F; Lu, T; Yuan, G; Yuan, Y, 2014
)
1.85
"Levulinic acid (LA) is a platform chemical derived from cellulosic biomass, and the expansion of LA utilization as a feedstock is important for production of a wide variety of chemicals. "( Bacterial production of short-chain organic acids and trehalose from levulinic acid: a potential cellulose-derived building block as a feedstock for microbial production.
Fukuoka, T; Habe, H; Kirimura, K; Kitamoto, D; Morita, T; Sato, S, 2015
)
2.09
"Levulinic acid is a derivative of cellulosic biomass, and 4-hydroxyvaleric acid is a potential precursor to bio-polymers and fuels."( Engineering substrate specificity of succinic semialdehyde reductase (AKR7A5) for efficient conversion of levulinic acid to 4-hydroxyvaleric acid.
Park, HY; Yeon, YJ; Yoo, YJ, 2015
)
1.35
"Levulinic acid is a sustainable platform molecule that can be upgraded to valuable chemicals and fuel additives. "( Levulinic Acid Biorefineries: New Challenges for Efficient Utilization of Biomass.
Pileidis, FD; Titirici, MM, 2016
)
3.32
"Levulinic acid is a known cigarette additive."( Industry research on the use and effects of levulinic acid: a case study in cigarette additives.
Connolly, GN; Cullen, DM; Ferris Wayne, G; Keithly, L, 2005
)
1.31

Effects

Levulinic acid (LEV) is a key building block chemical produced entirely from biomass. Levulinic Acid has potential as an important basic chemical material.

ExcerptReferenceRelevance
"Levulinic acid (LEV) has been identified as a key building block chemical produced entirely from biomass. "( A review on biomass-derived levulinic acid for application in drug synthesis.
Liu, J; Ma, L; Wang, C; Wang, N; Xu, Y; Zhang, M, 2022
)
2.46
"Levulinic acid has potential as an important basic chemical material. "( Experimental studies for levulinic acid production from whole kernel grain sorghum.
Fang, Q; Hanna, MA, 2002
)
2.06

Actions

ExcerptReferenceRelevance
"Levulinic acid also may enhance the binding of nicotine to neurons that ordinarily would be unresponsive to nicotine."( Industry research on the use and effects of levulinic acid: a case study in cigarette additives.
Connolly, GN; Cullen, DM; Ferris Wayne, G; Keithly, L, 2005
)
1.31

Treatment

ExcerptReferenceRelevance
"Treatment by levulinic acid resulted in a linear relation in both chlorophyll and carotenoid contents, during greening of etiolated French bean leaf discs."( Effects of delta-aminolevulinic acid on pigment formation and chlorophyllase activity in French bean leaf.
El-Saht, HM, 2000
)
0.97

Compound-Compound Interactions

ExcerptReferenceRelevance
"Recent studies showed that sodium acid sulfate (SAS) and levulinic acid (LA) in combination with sodium dodecyl sulfate (SDS) was effective in inactivating human pathogens on Romaine lettuce."( Acids in combination with sodium dodecyl sulfate caused quality deterioration of fresh-cut iceberg lettuce during storage in modified atmosphere package.
Fan, X; Guan, W; Huang, L, 2010
)
0.61

Dosage Studied

ExcerptRelevanceReference
" At a dosage of 300 mg treatment should be continued for at least 6 weeks."( [High-dosage oral magnesium therapy in arrhythmias. Results of an observational study in 1.160 patients with arrhythmia].
Holzgartner, H; Maier, E; Vierling, W, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (25 Product(s))

Product Categories

Product CategoryProducts
Other1
Produits laitiers, Produits fermentés, Desserts, Produits laitiers fermentés, Desserts lactés, Desserts lactés fermentés, Yaourts, Yaourts aromatisés1
Beauty & Personal Care21
Baby & Kids Products2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Acure Buildup Balancing Hemp & ACV Shampoo -- 8 fl ozAcureBeauty & Personal Carecitric acid, vinegar, betaine, citric acid, cocamidopropyl betaine, glycerin, levulinic acid, sodium cocoyl glutamate2024-11-29 10:47:42
Acure Daily Workout Shampoo Watermelon & Blood Orange -- 8 fl ozAcureBeauty & Personal Careorange, citric acid, betaine, citric acid, cocamidopropyl betaine, glycerin, levulinic acid, sodium cocoyl glutamate2024-11-29 10:47:42
Acure Juice Cleanse Supergreens & Adaptogens Shampoo -- 8 fl ozAcureBeauty & Personal Careorange, citric acid, betaine, camphor, citric acid, cocamidopropyl betaine, glycerin, levulinic acid, sodium cocoyl glutamate2024-11-29 10:47:42
Acure Simply Smoothing Shampoo Coconut -- 8 fl ozAcureBeauty & Personal Careorange, citric acid, betaine, citric acid, cocamidopropyl betaine, glycerin, levulinic acid, sodium cocoyl glutamate, vanillin2024-11-29 10:47:42
Acure Ultra Hydrating Body Wash -- 8 fl ozAcureBeauty & Personal Carecitric acid, benzaldehyde, citric acid, cocamidopropyl betaine, glycerin, hydroxyethylcellulose, levulinic acid, sodium benzoate2024-11-29 10:47:42
Acure Ultra Hydrating Shampoo Argan & Pumpkin -- 8 fl ozAcureBeauty & Personal Carecitric acid, benzaldehyde, betaine, citric acid, cocamidopropyl betaine, glycerin, levulinic acid, sodium cocoyl glutamate2024-11-29 10:47:42
Acure Vivacious Volume Shampoo Mint & Echinacea -- 8 fl ozAcureBeauty & Personal Carecitric acid, betaine, calendula, citric acid, cocamidopropyl betaine, glycerin, levulinic acid, sodium cocoyl glutamate2024-11-29 10:47:42
Attitude Sensitive Skin Body Lotion - Fragrance Free -- 16 fl ozAttitudeBeauty & Personal Carecitric acid, p-anisic acid, citric acid, triethyl citrate, glycerin, levulinic acid, raspberry ketone, stearyl alcohol2024-11-29 10:47:42
Cleo+Coco Magnesium Spray - Lavender Orange -- 3 fl ozCleo+CocoBeauty & Personal Careglycerin, glycolipids, levulinic acid, sodium cocoyl glutamate2024-11-29 10:47:42
Cleo+Coco Prebiotic Deodorant Spray - Cucumber Mint -- 3.38 fl ozCleo+CocoBeauty & Personal Care2,3-butanediol, glycerin, hexylene glycol, levulinic acid2024-11-29 10:47:42
Mustela Baby-Child Organic Hydrating Cream with Olive Oil and Aloe - Fragrance Free -- 5.07 fl ozMustelaBaby & Kids Productstocopherol, tocopherol, glycerin, levulinic acid, sodium benzoate2024-11-29 10:47:42
Mustela Diaper Rash Cream Skin Protectant with Zinc Oxide Fragrance Free -- 3.8 ozMustelaBaby & Kids Productscaprylyl glycol, ethyl linoleate, glycerin, levulinic acid, magnesium sulfate2024-11-29 10:47:42
Natracare Organic & Natural Cleansing Make-Up Removal Wipes -- 20 WipesNatraCareBeauty & Personal Careglyceryl oleate, citric acid, gluconolactone, citric acid, tocopherol, tocopherol, glycerin, microcrystalline cellulose, levulinic acid, sodium benzoate, sodiumcitrate2024-11-29 10:47:42
Natracare Organic Cotton Intimate Wipes -- 12 WipesNatraCareBeauty & Personal Carecitric acid, citric acid, glycerin, levulinic acid, maltodextrin2024-11-29 10:47:42
Pacha Soap Co Holiday Whipped Soap + Scrub - Peppermint Twist -- 8 ozPacha Soap CoBeauty & Personal Careclay, kaolin, levulinic acid2024-11-29 10:47:42
Pacha Soap Co Holiday Whipped Soap + Scrub - Spiced Pomegranate -- 8 ozPacha Soap CoBeauty & Personal Carelevulinic acid, sorbitol2024-11-29 10:47:42
Pacha Soap Co Holiday Whipped Soap + Scrub - Sugar & Spice -- 8 ozPacha Soap CoBeauty & Personal Carelevulinic acid, sorbitol, cane sugar2024-11-29 10:47:42
Pacha Soap Co Whipped Soap + Scrub - Coconut Papaya -- 8 ozPacha Soap CoBeauty & Personal Careclay, kaolin, levulinic acid, sorbitol2024-11-29 10:47:42
Pacha Soap Co Whipped Soap + Scrub - French Lavender -- 8 ozPacha Soap CoBeauty & Personal Careclay, kaolin, levulinic acid, sorbitol2024-11-29 10:47:42
Pacha Soap Co Whipped Soap + Scrub - Jasmine Gardenia -- 8 ozPacha Soap CoBeauty & Personal Careclay, kaolin, levulinic acid, sorbitol2024-11-29 10:47:42
Pacha Soap Co Whipped Soap + Scrub - Lemongrass Peppermint -- 8 ozPacha Soap CoBeauty & Personal Carelevulinic acid, sorbitol2024-11-29 10:47:42
Pacha Soap Co Whipped Soap + Scrub - Sand & Sea -- 8 ozPacha Soap CoBeauty & Personal Carelevulinic acid, sorbitol2024-11-29 10:47:42
Pacha Soap Co Whipped Soap + Scrub - Sea Mud -- 8 ozPacha Soap CoBeauty & Personal Careillite, levulinic acid, sorbitol2024-11-29 10:47:42

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
oxopentanoic acidA C5 fatty acid carrying an oxo group at any position.
straight-chain saturated fatty acidAny saturated fatty acid lacking a side-chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency0.56930.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency57.30720.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency63.87600.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency31.96600.000229.305416,493.5996AID743069; AID743075
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency21.872419.739145.978464.9432AID1159509
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 15 member 2Homo sapiens (human)Ki229.54350.79434.22108.0000AID612540
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
heme biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
protoporphyrinogen IX biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
heme biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
tetrapyrrole biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
monoatomic ion transportSolute carrier family 15 member 2Homo sapiens (human)
protein transportSolute carrier family 15 member 2Homo sapiens (human)
peptide transportSolute carrier family 15 member 2Homo sapiens (human)
peptidoglycan transportSolute carrier family 15 member 2Homo sapiens (human)
xenobiotic transportSolute carrier family 15 member 2Homo sapiens (human)
dipeptide transportSolute carrier family 15 member 2Homo sapiens (human)
renal absorptionSolute carrier family 15 member 2Homo sapiens (human)
regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathwaySolute carrier family 15 member 2Homo sapiens (human)
dipeptide import across plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
tripeptide import across plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
antibacterial innate immune responseSolute carrier family 15 member 2Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 15 member 2Homo sapiens (human)
proton transmembrane transportSolute carrier family 15 member 2Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
magnesium ion bindingDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
porphobilinogen synthase activityDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
zinc ion bindingDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
lyase activityDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
metal ion bindingDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
protein bindingSolute carrier family 15 member 2Homo sapiens (human)
peptide:proton symporter activitySolute carrier family 15 member 2Homo sapiens (human)
tripeptide transmembrane transporter activitySolute carrier family 15 member 2Homo sapiens (human)
dipeptide transmembrane transporter activitySolute carrier family 15 member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
cytosolDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
cytosolDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
phagocytic vesicle membraneSolute carrier family 15 member 2Homo sapiens (human)
plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
membraneSolute carrier family 15 member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
extracellular exosomeSolute carrier family 15 member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
plasma membraneSolute carrier family 15 member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID612540Binding affinity to human PepT2 in SKTP cells2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
AID1799605PBGS Assay from Article 10.1002/1439-7633(20010504)2: \\Inhibition studies of porphobilinogen synthase from Escherichia coli differentiating between the two recognition sites.\\2001Chembiochem : a European journal of chemical biology, May-04, Volume: 2, Issue:5
Inhibition studies of porphobilinogen synthase from Escherichia coli differentiating between the two recognition sites.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (395)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990104 (26.33)18.7374
1990's12 (3.04)18.2507
2000's47 (11.90)29.6817
2010's172 (43.54)24.3611
2020's60 (15.19)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.10 (24.57)
Research Supply Index6.02 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index112.78 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (66.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.49%)5.53%
Reviews22 (5.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other386 (94.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) With Carmustine Wafers (Gliadel) in the Surgical Management of Primary Glioblastoma (GALA-5 Trial) [NCT01310868]Phase 259 participants (Actual)Interventional2011-05-31Completed
A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine [NCT02101931]Phase 3100 participants (Actual)Interventional2014-03-31Completed
The Absorption of Supplemental Magnesium Oxide Compared to Magnesium Citrate in Healthy Subjects With no Apparent Heart Disease [NCT00994006]Phase 441 participants (Actual)Interventional2010-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT01310868 (3) [back to overview]Survival at 24 Months
NCT01310868 (3) [back to overview]Time to Clinical Progression
NCT01310868 (3) [back to overview]Safety, Tolerability, and Feasibility of Combination Intra-operative 5-ALA and Gliadel Wafers Prior to Adjuvant Radiotherapy Plus Temozolomide

Survival at 24 Months

(NCT01310868)
Timeframe: from the date of surgery to 24 months

Interventionmonths (Median)
5-ALA and Gliadel Wafers15

[back to top]

Time to Clinical Progression

(NCT01310868)
Timeframe: from the date of surgery to the date of the first MRI scan fitting the criteria for progression, or the date the clinical detrioration or death was first reported

Interventionmonths (Median)
5-ALA and Gliadel Wafers9.5

[back to top]

Safety, Tolerability, and Feasibility of Combination Intra-operative 5-ALA and Gliadel Wafers Prior to Adjuvant Radiotherapy Plus Temozolomide

"Procedure compliance: Proportion of 5-ALA resected patients who received Carmustine wafer implants (e.g to take into account rates of patients who did not receive Carmustine wafer implants due to 1) ventricular breach, 2) inaccurate peri-operative diagnosis, 3) intra-operative surgical decision)~Post-operative complication rate: Proportion of patients with a new post-operative deficit or surgical complication (wound infection, CSF leakage, intracranial hypertension)~No. of patients with chemoRT delay (i.e number who do not begin chemoRT 6 weeks after surgery) due to surgical complications*~No. of patients failing to start chemoRT due to surgical complications rather than tumour progression~No. of patients failing to complete chemoRT without interruption (RT with concomitant chemotherapy, and RT with concomitant plus adjuvant chemotherapy)~Proportion of patients with a lower WHO performance status after surgery with Carmustine wafers (at first post-operative clinic visit)" (NCT01310868)
Timeframe: Date of surgery to end of temozolomide and radiotherapy treatment (up to 34 weeks)

InterventionParticipants (Count of Participants)
5-ALA resected patients receiving carmustine waferNo. patients with post-op complicationsNo. Patients with chemoRT delayNo. pts failing to complete uninterrupted chemoRTno. pts w decr perform status after 5ala/carmustinno. pts not starting chemoRT due to surgical comp
5-ALA and Gliadel Wafers629645272

[back to top]